Savannah Chrisley Faces Federal Warning Over Claims

 was given a federal warning about her  website making 'misleading' claims regarding GLP-1s.

The star, 28, received a letter from the Food and Drug Administration () last month, after they reviewed her GoodGirlRX website, according to TMZ.

The FDA took issue with claims made by her company about compounded semaglutide and tirzepatide products.

They cited her use of phrases like 'FDA-approved meds,' 'FDA-approved options' and 'clinically proven GLP-1 results' as misleading.

The letter noted that compounded drug products like the ones sold on her website are not FDA-approved, and added that she was implying her products were 'evaluated for safety and effectiveness when they have not.' 

The Daily Mail has reached out to Chrisley for comment. 

Chrisley was notified that the website was in violation of federal law, and given 15 business days to implement corrections or face potential legal repercussions.

It appears the star has already made some changes on the website to comply.

Last November, Chrisley revealed her plans to use weight-loss drugs to help shed the 25 pounds she's been wanting to lose